Politician trade (House)

Becton Dickinson (BDX): Rep. Thomas H. Kean Jr. (NJ07) disclosed a purchase $1K–$15K

Rep. Thomas H. Kean Jr. (NJ07) disclosed a purchase of Becton Dickinson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
35 days
Disclosure lag
Traded
May 13, 2025
Disclosed
Jun 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 5, 2025CongressDisclosed sale of BDX — reported range $15,001 - $50,000
  2. Mar 18, 2025InsiderOfficer sold ~$106K of BDX shares in the open market
  3. Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  4. Apr 9, 2025InsiderOfficer sold ~$94K of BDX shares in the open market
  5. May 13, 2025 · this disclosureCongressDisclosed purchase of BDX — reported range $1,001 - $15,000

What came next

  1. May 15, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  2. Jun 2, 2025InsiderOfficer sold ~$200K of BDX shares in the open market
  3. Jun 17, 2025Congress · 1 personMembers of Congress: 2 purchases
  4. Jun 24, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  5. Jul 8, 2025FDARecall: BD Trucount Controls, 30 Test - REF: 664343, RxOnly, IVD
  6. Jul 8, 2025FDARecall: BD Trucount Controls, 30 Test - REF: 340335
  7. Jul 8, 2025FDARecall: BD Alaris Pump Infusion Sets REF: 10013186, BD Alaris Pump Infusion Set, Back Check Valve, 3 SmartSite Y-sites LVP 60D DEHP FREE 3SS CV; REF: 2452-0007, BD Ala…
  8. Jul 10, 2025FDAFDA device clearance: Marquee™ Disposable Core Biopsy Instrument and Instrument Kit
  9. Jul 10, 2025FDARecall: Description/REF: BD PYXIS MEDBANK MINI 1FH-1FM/169-137, BD PYXIS MEDBANK MINI 4HM/169-113, BD PYXIS MEDBANK MINI 4HH/169-112, BD PYXIS MEDBANK MINI 3HH-1HM/169…
  10. Jul 11, 2025FDAFDA device clearance: BD Cathena™ Safety IV Catheter
  11. Jul 17, 2025FDARecall: SureStep Foley Tray System Bardex I.C. Complete Care Infection Control Foley Catheter Tray, REF: A303316A
  12. Jul 17, 2025FDARecall: SureStep Foley Tray System Lubri-Sil I.C. Complete Care Infection Control Foley Catheter Tray, REF: A303414A
  13. Jul 17, 2025FDARecall: SureStep Foley Tray System BARD¿ Lubri-Sil Foley Catheter Tray, REF: A942216
  14. Jul 18, 2025Insider · 1 personInsiders: 2 sales (~$214K)
  15. Jul 24, 2025FDAFDA device clearance: Onflex™ Mesh
  16. Jul 25, 2025FDAFDA device clearance: BD Nexiva™ Closed IV Catheter System
  17. Jul 29, 2025FDAFDA device clearance: BD Plastipak™ Syringe
  18. Aug 8, 2025FDAFDA device clearance: BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)
  19. Aug 8, 2025InsiderDirector sold ~$166K of BDX shares in the open market
  20. Aug 11, 2025InsiderDirector purchased ~$1.01M of BDX shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Rep. Thomas H. Kean Jr. (NJ07)

The full history of Rep. Thomas H. Kean Jr. (NJ07) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Becton Dickinson (BDX) stock, and how much?

Rep. Thomas H. Kean Jr. (NJ07) disclosed a purchase of Becton Dickinson in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: May 13, 2025. Disclosed: Jun 17, 2025. That is 35 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Becton Dickinson recently?

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.

Does this mean BDX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data